{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:28:41Z","timestamp":1762867721112,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.endien.2021.08.009","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T09:11:13Z","timestamp":1667639473000},"page":"576-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Carbohydrate metabolism impairment in children and adolescents with cystic fibrosis"],"prefix":"10.1016","volume":"69","author":[{"given":"Janire","family":"Escudero Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Mart\u00edn Rivada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"Uribe Posada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Sanz Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Argente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel \u00c1ngel","family":"Martos-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Supl 2","key":"10.1016\/j.endien.2021.08.009_bib0005","first-page":"71","article-title":"Nutrici\u00f3n, fibrosis qu\u00edstica y aparato digestivo","volume":"23","author":"Olveira","year":"2008","journal-title":"Nutr Hosp"},{"issue":"3","key":"10.1016\/j.endien.2021.08.009_bib0010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.anpedi.2009.06.020","article-title":"Protocolo de diagn\u00f3stico y seguimiento de los pacientes con fibrosis qu\u00edstica","volume":"71","author":"Barrio","year":"2009","journal-title":"An Pediatr"},{"issue":"Suppl 2","key":"10.1016\/j.endien.2021.08.009_bib0015","first-page":"61","article-title":"Alteraci\u00f3n del Metabolismo Hidrocarbonado en la Fibrosis Qu\u00edstica","volume":"60","author":"Barrio","year":"2004","journal-title":"An Pediatr"},{"issue":"Suppl 1","key":"10.1016\/j.endien.2021.08.009_bib0020","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2337\/dc21-S002","article-title":"Classification and diagnosis of diabetes","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.endien.2021.08.009_bib0025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MOP.0000000000000251","article-title":"Advances in the detection and management of cystic fibrosis-related diabetes","volume":"27","author":"Hameed","year":"2015","journal-title":"Curr Opin Pediatr"},{"issue":"27","key":"10.1016\/j.endien.2021.08.009_bib0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/pedi.12732","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: management of cystic fibrosis-related diabetes in children and adolescents","volume":"19","author":"Moran","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"10.1016\/j.endien.2021.08.009_bib0035","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2337\/dc10-2289","article-title":"Hyperglycemia and death in cystic fibrosis\u2013related diabetes","volume":"34","author":"Adler","year":"2011","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.endien.2021.08.009_bib0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/CS20030333","article-title":"Effect of hyperglycaemia on glucose concentration of human nasal secretions","volume":"106","author":"Wood","year":"2004","journal-title":"Clin Sci"},{"key":"10.1016\/j.endien.2021.08.009_bib0045","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the Cystic Fibrosis Related Diabetes Therapy Trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2021.08.009_bib0050","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2021.08.009_bib0055","first-page":"CD004730","article-title":"Insulin and oral agents for managing cystic fibrosis-related diabetes","volume":"4","author":"Onady","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 20","key":"10.1016\/j.endien.2021.08.009_bib0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/pedi.12178","article-title":"International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents","volume":"15","author":"Moran","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.endien.2021.08.009_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc09-1492","article-title":"Early glucose abnormalities in cystic fibrosis are preceded by por weight gain","volume":"33","author":"Hameed","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2021.08.009_bib0070","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc10-1604","article-title":"Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis","volume":"34","author":"Brodsky","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2021.08.009_bib0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/jpem-2016-0184","article-title":"Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?","volume":"30","author":"Mainguy","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.endien.2021.08.009_bib0080","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc08-1925","article-title":"Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study","volume":"32","author":"O\u2019Riordan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2021.08.009_bib0085","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-09-1020","article-title":"Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system","volume":"162","author":"Schiafni","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endien.2021.08.009_bib0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S2213-8587(13)70015-9","article-title":"New insights into cystic fibrosis-related diabetes in children","volume":"1","author":"Ode","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.endien.2021.08.009_bib0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fendo.2018.00020","article-title":"Cystic fibrosis-related diabetes","volume":"9","author":"Kayani","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.endien.2021.08.009_bib0100","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1002\/ppul.23762","article-title":"CF-related diabetes: containing the metabolic miscreant of cystic fibrosis","volume":"52","author":"Moheet","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.endien.2021.08.009_bib0105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1464-5491.2004.01219.x","article-title":"Conventional measures underestimate glycaemia in CF patients","volume":"21","author":"Dobson","year":"2004","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.endien.2021.08.009_bib0110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.diabet.2008.05.010","article-title":"No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes","volume":"34","author":"Godbout","year":"2008","journal-title":"Diabetes Metab"},{"issue":"5","key":"10.1016\/j.endien.2021.08.009_bib0115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.anpedi.2012.05.015","article-title":"Alteraciones hidrocarbonadas en pacientes imp\u00faberes con fibrosis qu\u00edstica","volume":"77","author":"Mart\u00edn-Fr\u00edas","year":"2012","journal-title":"An Pediatr"},{"issue":"7","key":"10.1016\/j.endien.2021.08.009_bib0120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1399-5448.2009.00632.x","article-title":"Oral glucose tolerance testing in children with cystic fibrosis","volume":"11","author":"Ode","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.endien.2021.08.009_bib0125","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2337\/dc12-0246","article-title":"Patterns of insulin concentration during the OGTT predict the risk of type 2 diabetes in Japanese American","volume":"36","author":"Hayashi","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endien.2021.08.009_bib0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1183\/09031936.00161011","article-title":"Age- and height-based prediction bias in spirometry reference equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.endien.2021.08.009_bib0135","doi-asserted-by":"crossref","first-page":"e1793","DOI":"10.1210\/clinem\/dgaa932","article-title":"Glucose tolerance stages in cystic fibrosis are identified by a unique pattern of defects of beta-cell function","volume":"106","author":"Piona","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.endien.2021.08.009_bib0140","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/ajrccm.162.3.9904075","article-title":"Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline","volume":"162","author":"Milla","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.endien.2021.08.009_bib0145","doi-asserted-by":"crossref","first-page":"673539","DOI":"10.3389\/fendo.2021.673539","article-title":"Diabetes and prediabetes in children with cystic fibrosis: a systematic review of the literature and recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED)","volume":"12","author":"Mozzillo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.endien.2021.08.009_bib0150","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jcf.2009.04.010","article-title":"Demographics of glucose metabolism in cystic fibrosis","volume":"8","author":"Van den Berg","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.endien.2021.08.009_bib0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-10-1003","article-title":"Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients","volume":"165","author":"Battezatti","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endien.2021.08.009_bib0160","doi-asserted-by":"crossref","first-page":"e12565","DOI":"10.1111\/ijpo.12565","article-title":"Sex, puberty, and ethnicity have a strong influence on growth and metabolic comorbidities in children and adolescents with obesity: report on 1300 patients (the Madrid Cohort)","volume":"14","author":"Martos-Moreno","year":"2019","journal-title":"Pediatr Obes"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018022001500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018022001500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:16:35Z","timestamp":1762866995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018022001500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2530018022001500"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2021.08.009","relation":{},"ISSN":["2530-0180"],"issn-type":[{"type":"print","value":"2530-0180"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbohydrate metabolism impairment in children and adolescents with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2021.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2021.08.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}